Search

Your search keyword '"Paoli, L."' showing total 57 results

Search Constraints

Start Over You searched for: Author "Paoli, L." Remove constraint Author: "Paoli, L." Database Unpaywall Remove constraint Database: Unpaywall
57 results on '"Paoli, L."'

Search Results

1. P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38 MONOCLONAL ANTIBODY: A RETRO-PROSPECTIVE ITALIAN OBSERVATIONAL STUDY

3. Photosynthetic traits and biochemical responses in strawberry (Fragaria × ananassa Duch.) leaves supplemented with LED lights

4. Critical Assessment of Metagenome Interpretation - the second round of challenges

5. DISSECTING THE GENETICS OF DIFFERENT ANATOMICAL COMPARTMENTS OF SMALL LYMPHOCYTIC LYMPHOMA WITH A MULTIREGIONAL SEQUENCING APPORACH

6. ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS MEDIATED BY EPIGENETIC PLASTICITY OF RESIDUAL DISEASE AND BY‐PASS SIGNALING VIA MAPK PATHWAY

11. Impact of forest management on threatened epiphytic macrolichens: evidence from a Mediterranean mixed oak forest (Italy)

12. PF227 PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE

13. INTERNATIONAL PROGNOSTIC SCORE FOR EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (IPS-A)

14. PF602 OUTCOME OF EXTRA-MEDULLARY DISEASE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH NEW DRUGS

19. Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

20. A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma

23. Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

30. Can we compare lichen diversity data? A test with skilled teams

32. Lenalidomide−prednisone induction followed by lenalidomide−melphalan−prednisone consolidation and lenalidomide−prednisone maintenance in newly diagnosed elderly unfit myeloma patients

35. Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C

42. Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia

43. Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21

44. CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia

49. Data analysis methods for non-Gaussian, nonstationary and nonlinear features and their application to VIRGO

50. Status of VIRGO

Catalog

Books, media, physical & digital resources